Cite
MLA Citation
Kees Bol et al.. “814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A863. http://access.bl.uk/ark:/81055/vdc_100144722085.0x000003